94 related articles for article (PubMed ID: 18217307)
21. No effect of Cimicifuga racemosa extract on serum interleukin-6 levels and prostacyclin production by human endothelial cells.
Pineda B; García-Pérez MA; Vázquez F; Juliá MD; Tarín JJ; Hermenegildo C; Cano A
Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):93-4. PubMed ID: 19233537
[No Abstract] [Full Text] [Related]
22. [Premature ovarian insufficiency and pregnancy].
López X; Arteaga E; Fernández C
Rev Chil Obstet Ginecol; 1989; 54(2):83-5. PubMed ID: 2490172
[No Abstract] [Full Text] [Related]
23. The timing of estrogen therapy after ovariectomy--implications for neurocognitive function.
Maki PM
Nat Clin Pract Endocrinol Metab; 2008 Sep; 4(9):494-5. PubMed ID: 18648334
[No Abstract] [Full Text] [Related]
24. Regarding "Hormone Replacement Therapy Prescription after Premature Surgical Menopause".
Iavazzo C; Gkegkes I
J Minim Invasive Gynecol; 2020; 27(6):1425. PubMed ID: 32344026
[No Abstract] [Full Text] [Related]
25. [General mechanisms of premature ovarian failure and clinical check-up].
Christin-Maitre S; Braham R
Gynecol Obstet Fertil; 2008 Sep; 36(9):857-61. PubMed ID: 18706847
[TBL] [Abstract][Full Text] [Related]
26. [Autoimmune hepatitis induced by Actaea racemosa. Side affects of an herb extract].
van de Meerendonk HW; van Hunsel FP; van der Wiel HE
Ned Tijdschr Geneeskd; 2009 Feb; 153(6):246-9. PubMed ID: 19271447
[No Abstract] [Full Text] [Related]
27. [Alternative therapies for menopausal women].
von Hagens C; Reinhard-Hennch B; Strowitzki T
MMW Fortschr Med; 2008 Oct; 150(43):29-32. PubMed ID: 19031581
[No Abstract] [Full Text] [Related]
28. Effects of Trifolium pratense and Cimicifuga racemosa on the endometrium of Wistar rats.
Alves DL; Lima SM; da Silva CR; Galvão MA; Shanaider A; de Almeida Prado RA; Aoki T
Maturitas; 2008 Dec; 61(4):364-70. PubMed ID: 19095386
[TBL] [Abstract][Full Text] [Related]
29. Hormone replacement therapy post Women's Health Initiative study: where do we stand?
Calleja-Agius J; Brincat MP
Curr Opin Obstet Gynecol; 2008 Dec; 20(6):513-8. PubMed ID: 18989125
[TBL] [Abstract][Full Text] [Related]
30. [Low-dose hormonal therapy during climacteric].
Carranza Lira S
Ginecol Obstet Mex; 2008 May; 76(5):267-74. PubMed ID: 18798431
[TBL] [Abstract][Full Text] [Related]
31. [Controversies surrounding on hormone replacement therapy during menopause].
Cravioto MC
Gac Med Mex; 2006; 142 Suppl 2():33-42. PubMed ID: 19031677
[TBL] [Abstract][Full Text] [Related]
32. [Phytotherapy and hormone replacement therapy. Optimisation of administration during menopause].
Damianova V; Damianov L
Akush Ginekol (Sofiia); 2006; 45 Suppl 2():25-8. PubMed ID: 16922343
[No Abstract] [Full Text] [Related]
33. Treatment of menopausal symptoms.
Tong IL
Compr Ther; 2008; 34(1):41-7. PubMed ID: 18681111
[TBL] [Abstract][Full Text] [Related]
34. Patient information. Is hormone replacement therapy for me?
JAAPA; 2009 Jul; 22(7):58. PubMed ID: 19697574
[No Abstract] [Full Text] [Related]
35. Caution, balance needed in recommending herbals over hormone replacement.
Franco K
J Womens Health Gend Based Med; 1999 May; 8(4):431-2. PubMed ID: 10839691
[No Abstract] [Full Text] [Related]
36. Inhibition of inducible nitric oxide synthesis by Cimicifuga racemosa (Actaea racemosa, black cohosh) extracts in LPS-stimulated RAW 264.7 macrophages.
Schmid D; Gruber M; Woehs F; Prinz S; Etzlstorfer B; Prucker C; Fuzzati N; Kopp B; Moeslinger T
J Pharm Pharmacol; 2009 Aug; 61(8):1089-96. PubMed ID: 19703353
[TBL] [Abstract][Full Text] [Related]
37. Ovarian failure following cancer treatment: current management and quality of life.
Absolom K; Eiser C; Turner L; Ledger W; Ross R; Davies H; Coleman R; Hancock B; Snowden J; Greenfield D;
Hum Reprod; 2008 Nov; 23(11):2506-12. PubMed ID: 18664468
[TBL] [Abstract][Full Text] [Related]
38. [Personal losses, menopause, and estrogen treatment].
Martin-Du-pan RC
Rev Med Suisse; 2009 Jun; 5(206):1292. PubMed ID: 19579430
[No Abstract] [Full Text] [Related]
39. Early-onset menopause. Managing its special challenges.
Mayo Clin Womens Healthsource; 2007 Feb; 11(2):4-5. PubMed ID: 17192755
[No Abstract] [Full Text] [Related]
40. Isopropanolic Cimicifuga racemosa is favorable on bone markers but neutral on an osteoblastic cell line.
García-Pérez MA; Pineda B; Hermenegildo C; Tarín JJ; Cano A
Fertil Steril; 2009 Apr; 91(4 Suppl):1347-50. PubMed ID: 18555220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
